The median levels of faecal B2M mRNA (P<0.05), CEA mRNA (P<0.001), and E-cad mRNA (P<0.001, Table 2) were also significantly higher in CRC patients than in control subjects. The gene discussed is B2M; the disease is colorectal carcinoma.